Simplexa™ GBS Direct MOL3550
Ref MOL3550
Simplexa GBS Direct MOL3550 (MOL5290) is an in vitro diagnostic device (EU IVDD general IVD; FDA Class II; EMDN category strep. b detection by na reagents) made by DiaSorin Molecular LLC, registered in EUDAMED on 9 Oct 2026 (Basic UDI-DI B-20816101025644), cleared under FDA 510(k) K182467 on 7 Nov 2018 and listed in FDA GUDID since 20 Nov 2018 (UDI-DI 20816101025644), active as of 7 Nov 2026.
Active
CE IVDD 510(k)
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD EUDAMED | NumberB-20816101025644 20816101025644 | Date9 Oct 2026 | StatusActive |
| United States | GUDID listing GUDID | Number20816101025644 | Date20 Nov 2018 | StatusListed |
| United States | FDA 510(k)SESE GUDID | NumberK182467 | Date7 Nov 2018 | StatusActive |
Official records
- EUDAMED public site B-20816101025644
- AccessGUDID record 20816101025644
- FDA 510(k) database K182467
From the FDA record
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI B-20816101025644 registered 9 Oct 2026 Active
- FDA 510(k) K182467 decided 7 Nov 2018 Active
- FDA GUDID UDI-DI 20816101025644 listed 20 Nov 2018 Listed
Timeline
- Cleared FDA 510(k) K182467
- Listed FDA GUDID 20816101025644
- Registered EUDAMED B-20816101025644
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Simplexa™ GBS Direct
- Generic name
- Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
- Model / Ref / Catalog
- MOL3550, MOL5290
- Primary DI / UDI-DI
- 20816101025644
- Basic UDI-DI
- B-20816101025644
- 510(k) Number
- FDA product code
- OOI, NJR
- EMDN code
- W0105011104 Strep. b detection by na reagents
- GMDN term
- Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class IVD General EUDAMEDClass II GUDID
- Regulation number
- 862.2570, 866.3740
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Italy
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class IVD General | Class II |
Similar devices in this category
Other devices filed under STREP. B DETECTION BY NA REAGENTS.
- Strep B Rapid Test Cassette ISB-502 by Hangzhou Alltest Biotech.Co.,Ltd.
- PCR-based Group B Streptococcus Test Kit (Fluorometric PCR) ID020 by Beijing Applied Biological Technologies Co., Ltd.
- BD MAX™ GBS 441772 by Becton, Dickinson and Company
- Streptococcus Group B antisera by Genhawk (Wuhan) Biotech Co., Ltd.
- GBS Real-time PCR Kit HBRT-GBS by Chaozhou Hybribio Biochemistry Ltd.
- Panther Fusion® PRD-04484 by Hologic
- Group B Streptococcus Nucleic Acid Detection Kit (Real-Time PCR) 213601 by Yaneng BIOscience (Shenzhen) Co., Ltd.
- Group B Streptococcus DNA Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) S3056E by Sansure Biotech Inc.
- FlashDetect 6018027105-CE by Coyote Bioscience Co., Ltd.